From: Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020
Basal | 6 months | p | |
---|---|---|---|
Basal insulin | 46.9% | 86.3% | < 0.0001 |
Bolus Insulin | 19.7% | 52.5% | < 0.0001 |
Premixed insulin | 13.6% | 9.4% | 0.261 |
Metformin | 70.8% | 33.1% | < 0.0001 |
iDPP4 | 46.3% | 23.0% | < 0.0001 |
aGLP1 | 3.4% | 2.2% | 0.524 |
iSGLT2 | 10.9% | 7.2% | 0.278 |
Sulfonylurea | 8.8% | 1.4% | 0.005 |
Glinides | 8.2% | 1.4% | 0.008 |
Pioglitazone | 0% | 0% | - |
Statin | 37.4% | 41.7% | 0.456 |
Ezetimibe | 0.7% | 2.2% | 0.287 |
Antihypertensive | 22.5% | 25.2% | 0.588 |